Cargando…
Antibody-Drug Conjugates: Possibilities and Challenges
The design of Antibody Drug Conjugates (ADCs) as efficient targeting agents for tumor cell is still in its infancy for clinical applications. This approach incorporates the antibody specificity and cell killing activity of chemically conjugated cytotoxic agents. Antibody in ADC structure acts as a t...
Autores principales: | Nejadmoghaddam, Mohammad-Reza, Minai-Tehrani, Arash, Ghahremanzadeh, Ramin, Mahmoudi, Morteza, Dinarvand, Rassoul, Zarnani, Amir-Hassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Avicenna Research Institute
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359697/ https://www.ncbi.nlm.nih.gov/pubmed/30800238 |
Ejemplares similares
-
Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy
por: Nejadmoghaddam, Mohammad-Reza, et al.
Publicado: (2017) -
Profiling and quantitative evaluation of three Nickel-Coated magnetic matrices for purification of recombinant proteins: lelpful hints for the optimized nanomagnetisable matrix preparation
por: Nejadmoghaddam, Mohammad Reza, et al.
Publicado: (2011) -
Conjugation of R-Phycoerythrin to a Polyclonal Antibody and F (ab')2 Fragment of a Polyclonal Antibody by Two Different Methods
por: Mahmoudian, Jafar, et al.
Publicado: (2010) -
Production of Monoclonal Antibody against Human Nestin
por: Hadavi, Reza, et al.
Publicado: (2010) -
Enzyme and Thermo Dual-stimuli Responsive DOX Carrier Based on PNIPAM Conjugated Mesoporous Silica
por: Ebrahimi, Seyyed Mostafa, et al.
Publicado: (2022)